Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	145.42	53.51	-21.15	-44.88	-42.04
Depreciation & Amortization	13.96	6.55	2.85	1.86	1.22
Stock-Based Compensation	130.26	116.01	82.47	51.97	26.18
Other Adjustments	-85.28	-8.11	1.27	0.81	1.38
Change in Receivables	-26.23	-2.6	-30.22	-27.02	-9.24
Changes in Inventories	-65.18	-46.23	-22	5.35	-8.75
Changes in Accounts Payable	-3.75	0.6	9.3	14.36	4.78
Changes in Accrued Expenses	6.12	12.87	6.9	11.94	7.06
Changes in Other Operating Activities	1.65	-2.34	-4.76	-2.82	-0.7
Operating Cash Flow	116.98	130.25	24.65	11.57	-20.12
Operating Cash Flow Growth	-10.19%	428.32%	113.09%	-	-
Capital Expenditures	-38.5	-39.12	-23.63	-9.1	-4.67
Purchases of Investments	-250.44	-418.6	-281.44	-10.5	-9.99
Proceeds from Sale of Investments	310.38	344.61	10.25	-	43.8
Investing Cash Flow	21.45	-113.12	-294.82	-19.6	29.14
Long-Term Debt Repaid	-	-	-	-24.5	-
Net Long-Term Debt Issued (Repaid)	-	-	-	-24.5	-
Issuance of Common Stock	14.61	27.77	31.11	259.62	14.95
Repurchase of Common Stock	-175.02	-75	-	-	-
Net Common Stock Issued (Repurchased)	-160.41	-47.23	31.11	259.62	14.95
Other Financing Activities	-23.04	-5.17	-17.16	-0.04	-
Financing Cash Flow	-183.45	-52.39	13.95	235.08	14.95
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.31	-0.12	0.16	0.08	-0.02
Net Cash Flow	-45.34	-35.39	-256.06	227.13	23.95
Free Cash Flow	78.48	91.12	1.02	2.47	-24.79
Free Cash Flow Growth	-13.88%	8798.73%	-58.59%	-	-
FCF Margin	8.61%	11.35%	0.16%	0.61%	-10.62%
Free Cash Flow Per Share	2.64	2.98	0.03	0.09	-0.91
Levered Free Cash Flow	59.73	-14.17	-52.5	-47.79	-43.1
Unlevered Free Cash Flow	27.1	-34.65	-74.14	-26.66	-40.98

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q